Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Nanotechnology Scaffolds for Alveolar Bone Regeneration

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In oral biology, tissue engineering aims at regenerating functional tissues through a series of key events that occur during alveolar/periodontal tissue formation and growth, by means of scaffolds that deliver signaling molecules and cells. Due to their excellent physicochemical properties and biomimetic features, nanomaterials are attractive alternatives offering many advantages for stimulating cell growth and promoting tissue regeneration through tissue engineering. The main aim of this article was to review the currently available literature to provide an overview of the different nano-scale scaffolds as key factors of tissue engineering for alveolar bone regeneration procedures. In this narrative review, PubMed, Medline, Scopus and Cochrane electronic databases were searched using key words like “tissue engineering”, “regenerative medicine”, “alveolar bone defects”, “alveolar bone regeneration”, “nanomaterials”, “scaffolds”, “nanospheres” and “nanofibrous scaffolds”. No limitation regarding language, publication date and study design was set. Hand-searching of the reference list of identified articles was also undertaken. The aim of this article was to give a brief introduction to review the role of different nanoscaffolds for bone regeneration and the main focus was set to underline their role for alveolar bone regeneration procedures.

          Related collections

          Most cited references96

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

          Among several promising new drug-delivery systems, liposomes represent an advanced technology to deliver active molecules to the site of action, and at present several formulations are in clinical use. Research on liposome technology has progressed from conventional vesicles (“first-generation liposomes”) to “second-generation liposomes”, in which long-circulating liposomes are obtained by modulating the lipid composition, size, and charge of the vesicle. Liposomes with modified surfaces have also been developed using several molecules, such as glycolipids or sialic acid. A significant step in the development of long-circulating liposomes came with inclusion of the synthetic polymer poly-(ethylene glycol) (PEG) in liposome composition. The presence of PEG on the surface of the liposomal carrier has been shown to extend blood-circulation time while reducing mononuclear phagocyte system uptake (stealth liposomes). This technology has resulted in a large number of liposome formulations encapsulating active molecules, with high target efficiency and activity. Further, by synthetic modification of the terminal PEG molecule, stealth liposomes can be actively targeted with monoclonal antibodies or ligands. This review focuses on stealth technology and summarizes pre-clinical and clinical data relating to the principal liposome formulations; it also discusses emerging trends of this promising technology.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.

            Design and functionalization strategies for multifunctional nanocarriers (e.g., nanoparticles, micelles, polymersomes) based on biodegradable/biocompatible polymers intended to be employed for active targeting and drug delivery are reviewed. This review will focus on the nature of the polymers involved in the preparation of targeted nanocarriers, the synthesis methods to achieve the desired macromolecular architecture, the selected coupling strategy, the choice of the homing molecules (vitamins, hormones, peptides, proteins, etc.), as well as the various strategies to display them at the surface of nanocarriers. The resulting morphologies and the main colloidal features will be given as well as an overview of the biological activities, with a special focus on the main in vivo achievements.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dendrimers and dendritic polymers in drug delivery.

              The unique properties of dendrimers, such as their high degree of branching, multivalency, globular architecture and well-defined molecular weight, make them promising new scaffolds for drug delivery. In the past decade, research has increased on the design and synthesis of biocompatible dendrimers and their application to many areas of bioscience including drug delivery, immunology and the development of vaccines, antimicrobials and antivirals. Recent progress has been made in the application of biocompatible dendrimers to cancer treatment, including their use as delivery systems for potent anticancer drugs such as cisplatin and doxorubicin, as well as agents for both boron neutron capture therapy and photodynamic therapy.
                Bookmark

                Author and article information

                Journal
                Materials (Basel)
                Materials (Basel)
                materials
                Materials
                MDPI
                1996-1944
                03 January 2020
                January 2020
                : 13
                : 1
                : 201
                Affiliations
                [1 ]Department of Biomedical, Surgical and Dental Sciences, University of Milano, 20122 Milan, Italy; silvio.taschieri@ 123456unimi.it (S.T.); aldo.gianni@ 123456unimi.it (G.A.B.); massimo.delfabbro@ 123456unimi.it (M.D.F.)
                [2 ]IRCCS Orthopedic Institute Galeazzi, Via Riccardo Galeazzi, 4, 20161 Milano MI, Italy; paolo_savadori@ 123456yahoo.it
                [3 ]Dental and Maxillo-Facial Surgery Unit, IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Via Francesco Sforza 35, 20122 Milan, Italy; emma.grecchi@ 123456gmail.com
                [4 ]ASST Fatebenefratelli Sacco Hospital, Dentistry Department, Via Giovanni Battista Grassi, 74, 20157 Milan, Italy; girolamo.donati@ 123456asst-fbf-sacco.it
                Author notes
                [* ]Correspondence: funda.goker@ 123456unimi.it ; Tel.: +39-02-5031-9950
                Author information
                https://orcid.org/0000-0002-2354-361X
                https://orcid.org/0000-0002-7866-5024
                https://orcid.org/0000-0001-7144-0984
                Article
                materials-13-00201
                10.3390/ma13010201
                6982209
                31947750
                defc33f5-6e39-409d-b07d-fec4ff1948cc
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 04 November 2019
                : 31 December 2019
                Categories
                Review

                scaffolds,nanomaterials,tissue engineering,regenerative medicine,alveolar bone regeneration

                Comments

                Comment on this article